Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Glioma 1Glioblastoma 1Epitheliod Malignant Pleural Mesothelioma 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 3Specimen Handling 2Radiotherapy 2Ipilimumab 2CTLA-4 Antigen 2tocilizumab 1talimogene laherparepvec 1sonidegib 1prednylidene 1poly ICLC 1pembrolizumab 1flt3 ligand protein 1deltacortene 1cemiplimab 1Tomography, Optical Coherence 1Tacrolimus 1Radiation 1Prednisone 1Papillomavirus Vaccines 1Mohs Surgery 1Microscopy, Confocal 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Blood Specimen Collection 1Biopsy 1BO-112 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Basal Cell × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT05020912 2026-06-01

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Case Comprehensive Cancer Center

Phase 2 Active not recruiting
18 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡